Multiple Sclerosis Agents

Random Miscellaneous Quiz

Can you name the Multiple Sclerosis Agents?

Quiz not verified by Sporcle

How to Play
Axathioprine class
Use: treatment of spasticity
Daclizumab class
Venlafaxine class
Rituximab class
Tizanidine class
Modafinil class
SE: Thyroid disorders, ITP (with fatal brain hemorrhage), infections.
IFN beta 1-b (Betaseron) class
Dose: 1250 mg/day PO for 3-5 days
Glatiramer acetate class
Use: Fatigue
Duloxetine class
Second line agent: RRMS, SPMS, Progressive Relapsing MS
SE: Seizures at higher than recommended doses (contraindicated in pts with a hx of seizure)
Second line agent given IV monthy
Gabapentin class
MOA: Monoclonal Ab. Shows functional improvement not just slowing of decline
First line drugs for disease modification
Second line agent for RRMS that produces reduction in progression of disabilty
Use: Depression. Also helps with pain
Dose: Oral daily (first PO MS drug)
Use: Depression. Also helps with fatigue
Dose: SC injection every other day
Fingolimod class
Bupropion class
Mitoxantrone class
Tricyclic class
MOA: Immune modulator, exact mechanism not known.
MOA: Potassium channel blocker. Possibly increases conduction in demyelinated axons
Use: pain and paroxysmal disorders
Methylprednisone class
Alemtizumab class
Prednisone class
Second line agent: RRMS. Reduced relapses & progression of disability
IFN beta 1-a (Avonex) class
MOA: Antimetabolite and antifolate
Carbamazepine class
SE: Inj site rxn w/ high doses, flu-like s/s (responds well to naproxen), monitor liver fx, may develop neutralizing Ab, may increase depression.
MOA: Synthetic form of myelin basic PRO copolymer 1. Binds to MHC molecules. Competes w/ myelin antigens for presentation to T cells.
MOA: alkylating agent
IFN beta 1-a (Rebif) class
Second line agent MOA: monoclonal Ab
Cyclophosphamide class
Natalizumab class
SE: Risk of progressive multifocal leukoencephalopathy. Rare fatal viral (polymyxoma JC virus) reactivation infxn affecting white matter in immunosuppressed (only a risk to pts w/
Use: For pts who do not respond to corticosteroids during acute attacks
First line RRMS agent injected SC daily
Plasmapheresis class
Use: Fatigue, cognitive impairment (long acting agent)
Dose: Oral. In extreme cases intrathecal
MOA: Sphingosine 1-phosphate receptor modulator. Sequesters lymphocytes.
Dose: IV infusion every 3 months
Mycophenolate class
MOA: Purine analog
Methylphenidate class
Dose: IM weekly
Methotrexate class
MOA: Anti-organ rejection drug
MOA: Immunomodulator/antineoplastic
Off line agent used in the treatment of acute attacks
Dose: 1 gram/day IV for 3-5 days
SE: Localized inj site reactions. Self-limited (15-20 min) acute rxn resembling a panic attack (palpitations, dyspnea, flushing) -- not an indication to stop tx
SE: HR reduction of 10-20 bpm, occasionally bradyarrhythmias or AV block -- screen for cardiac dz (6 hr monitoring w/ first dose). Macular edema in 1% (reversible). Check varicella
Baclofen class
Dalfampridine class
Dose: SC injection 2-3 times weekly
Excreted by kidney: contraindicated in moderate to severe renal failure

You're not logged in!

Compare scores with friends on all Sporcle quizzes.
Sign Up with Email
Log In

You Might Also Like...

Show Comments